We have several tier-1 firms out positive on Monsanto (NYSE:MON) this AM:
- Merrill Lynch is raising their tgt to $165 from $155 (Reit Buy) noting that at its recent investor field event Monsanto indicated that fiscal 2009 biotech trait price increases will be above earlier expectations, particularly for triple stacked corn up 33% on average from 2008 versus June guidance of a 20% increase. MLCO's proprietary review of Monsanto’s just-issued price lists indicate that the trait increase approaches 50% for the premium product (VT triple) in the high-yield, high-rootworm pressure areas, but is roughly flat in lower-yielding, low rootworm pressure areas, which they believe will drive penetration rates. Second generation Roundup-tolerant soybeans will be priced $20/acre above first generation versus original expectations of $15....
...Notablecalls: I think these two calls serve to push the stock towards higher levels today. I feel that under overall positive tone the stock could reach $120+ in coming weeks.
Note that Citigroup is out with a positive Fert. call this AM, pushing Potash (NYSE:POT) as their Top Pick. This will surely help the positive sentiment.
PotashCorp (NYSE:POT): Citigroup adds Potash to their Top Picks Live list: - sell-off overdone
